Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Leases (2019 - 2023)

Historic Current Leases for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $1.4 million.

  • ADC Therapeutics' Current Leases rose 6970.06% to $1.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.4 million, marking a year-over-year increase of 6970.06%. This contributed to the annual value of $1.1 million for FY2022, which is 10650835.76% up from last year.
  • Per ADC Therapeutics' latest filing, its Current Leases stood at $1.4 million for Q3 2023, which was up 6970.06% from $1.6 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Current Leases ranged from a high of $1.6 million in Q2 2023 and a low of $1029.0 during Q4 2021
  • Over the past 5 years, ADC Therapeutics' median Current Leases value was $952500.0 (recorded in 2019), while the average stood at $862727.1.
  • Over the last 5 years, ADC Therapeutics' Current Leases had its largest YoY gain of 10650835.76% in 2022, and its largest YoY loss of 1749.01% in 2022.
  • ADC Therapeutics' Current Leases (Quarter) stood at $924000.0 in 2019, then plummeted by 99.89% to $1051.0 in 2020, then fell by 2.09% to $1029.0 in 2021, then skyrocketed by 106508.36% to $1.1 million in 2022, then grew by 29.17% to $1.4 million in 2023.
  • Its Current Leases was $1.4 million in Q3 2023, compared to $1.6 million in Q2 2023 and $1.4 million in Q1 2023.